definiens: means all Patents [ * * ] the [ * * ] that [ * * ] . For clarity, [COMPANY] Platform Patentsspecifically exclude : ( a ) RSV Antibody Patents ; and ( b ) any Patents Controlled by [COMPANY] to the extent that theyCover any invention or subject matter other than the manner in which [COMPANY] discovered the [COMPANY] RSV Antibodies.1.6 means ( a ) methods of discovery and optimization of antibodies, whichmethods include the use of synthetic DNA antibody libraries and engineered strains of yeast and interrogatingrepertoires generated through B - cell cloning, ( b ) all methods, materials and other Know - How used in the foregoing and(c ) platforms embodying any of the foregoing in ( a ) or ( b ), or components, component steps or other portions thereof;in each case, solely to the extent the foregoing either ( i ) are Covered by Patents Controlled by [COMPANY] or(ii ) constitute Confidential Information of [COMPANY] . For clarity, [COMPANY] Platform Technology includes technologyControlled by, or confidential or proprietary to, [COMPANY] that is used by [COMPANY] in the discovery and optimization ofany [COMPANY] RSV Antibody, in each case based on the manner in which [COMPANY] discovered or optimized such AdimabRSV Antibody, but not based on the specific composition of or any Sequence information regarding such AdimabRSV Antibody ( or any product containing an [COMPANY] RSV Antibody ), but [COMPANY] Platform Technology excludes:(A ) [COMPANY] RSV Antibodies ; and ( B ) technology Controlled by, or confidential or proprietary to, [COMPANY] that is relatedto : ( 1 ) product formulation ; ( 2 ) manufacturing, purification, or production ; ( 3 ) modification or optimization of antibodies;(4 ) RSV ( including any antigen representation thereof ), or any mechanism of action via interaction with RSV, ormethods of using antibodies based on their interaction with RSV ; or ( 5 ) if other than an IgG, the construct of anyProduct